Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Biotech Ingredient Market Growth in 2025?

Recent years have seen a significant expansion in the biotech ingredient market size. It is forecasted to rise from $59.9 billion in 2024 to $63.86 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.6%. This growth during the historic period can be linked to novel developments in the food and beverage sector, the escalating popularity of biofuel, the rising consumer demand for functional foods, and breakthroughs in genetic engineering.

What Is the Forecast for the Biotech Ingredient Market Size Through 2029?

The market size of biotech ingredients is predicted to witness robust expansion in the upcoming years, escalating to $83.5 billion in 2029 with a CAGR of 6.9%. The growth throughout the forecast period is likely due to the emphasis on customized nutrition, the widening of cell-based meat manufacturing, the advancement of therapeutic biotech components, bio ingredients aimed at waste minimization, and the transition to bioplastics. Significant trends during this predicted period encompass biotech-facilitated functional foods, biotech solutions intended for circular economy practices, therapeutic biotech components, biotech ingredients aimed at clean energy generation, and a worldwide focus on preserving biodiversity.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

What are the Key Market Players in Biotech Ingredient Market and How They’re Evolving?

Major companies operating in the biotech ingredient market include Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

What Are the Primary Growth Drivers in the Biotech Ingredient Market?

The expected surge in the biotech ingredient market can be contributed to the rising demand for generic medicines. A generic medicine, by definition, is a drug formulated to have identical properties to another already approved medicine. Biotech ingredients play an essential role in generic medicine, notably as a critical source for creating a variety of active ingredients that are remarkably similar to the original product, at a lower cost and increased effectiveness. The oversight for these substances is typically under an augmented set of regulations. For example, the Personalized Medicine Coalition, a professional membership organization based in the United States, reported that in 2022, the authorization of 12 new personalized medicines represented about 34% of all groundbreaking approved therapies. This is a notable upturn compared to preceding years. As a result, the surging demand for generic medicines is fuelling the expansion of the biotech ingredient market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9817&type=smp

What Are the Leading Segments in the Global Biotech Ingredient Industry?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

What Are the Key Market Trends in the Biotech Ingredient Industry?

The rise in technological progress is becoming a crucial trend that’s garnering attention in the biotech ingredient industry. To sustain their competitive edge in the market, key corporations in the biotech ingredient field are implementing novel technologies to create enhanced products. As an example, International Flavors & Fragrances Inc., a US-based firm specializing in the production of fragrance, biotech solutions, cosmetic energetics, and organic health elements, unveiled Aurist AGC in March 2023. This innovative biopolymer for hair care exemplifies the potential of the new DEB platform, leveraging IFF’s extensive biotechnological capabilities to deliver consistent, high-performance glamour solutions that can affect real change in the cosmeceutical sector. This ingredient utilizes IFF’s exclusive Designed Enzymatic Biopolymers (DEB) technology, a cutting-edge biotechnology able to generate unique biobased polysaccharides with distinct structures and product characteristics.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

What Is the Regional Outlook for the Biotech Ingredient Market?

Europe was the largest region in the biotech ingredient market in 2024. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9817

This Report Delivers Insight On:

1. How big is the biotech ingredient market, and how is it changing globally?

2. Who are the major companies in the biotech ingredient market, and how are they performing?

3. What are the key opportunities and risks in the biotech ingredient market right now?

4. Which products or customer segments are growing the most in the biotech ingredient market?

5. What factors are helping or slowing down the growth of the biotech ingredient market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model